Calculating The Fair Value Of Public Joint Stock Company KuibyshevAzot (MCX:KAZT)
In this article we are going to estimate the intrinsic value of Public Joint Stock Company KuibyshevAzot (MCX:KAZT) by taking the expected future cash flows and discounting them to today's value. This will be done using the Discounted Cash Flow (DCF) model. It may sound complicated, but actually it is quite simple!
Companies can be valued in a lot of ways, so we would point out that a DCF is not perfect for every situation. If you still have some burning questions about this type of valuation, take a look at the Simply Wall St analysis model.
Check out our latest analysis for KuibyshevAzot
The method
We are going to use a two-stage DCF model, which, as the name states, takes into account two stages of growth. The first stage is generally a higher growth period which levels off heading towards the terminal value, captured in the second 'steady growth' period. To begin with, we have to get estimates of the next ten years of cash flows. Seeing as no analyst estimates of free cash flow are available to us, we have extrapolate the previous free cash flow (FCF) from the company's last reported value. We assume companies with shrinking free cash flow will slow their rate of shrinkage, and that companies with growing free cash flow will see their growth rate slow, over this period. We do this to reflect that growth tends to slow more in the early years than it does in later years.
Generally we assume that a dollar today is more valuable than a dollar in the future, so we need to discount the sum of these future cash flows to arrive at a present value estimate:
10-year free cash flow (FCF) forecast
2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | |
Levered FCF (RUB, Millions) | ₽5.18b | ₽5.20b | ₽5.34b | ₽5.55b | ₽5.83b | ₽6.16b | ₽6.54b | ₽6.97b | ₽7.44b | ₽7.95b |
Growth Rate Estimate Source | Est @ -2.39% | Est @ 0.52% | Est @ 2.56% | Est @ 3.99% | Est @ 4.99% | Est @ 5.69% | Est @ 6.18% | Est @ 6.52% | Est @ 6.76% | Est @ 6.93% |
Present Value (RUB, Millions) Discounted @ 14% | ₽4.5k | ₽4.0k | ₽3.6k | ₽3.2k | ₽3.0k | ₽2.7k | ₽2.5k | ₽2.4k | ₽2.2k | ₽2.1k |
("Est" = FCF growth rate estimated by Simply Wall St)
Present Value of 10-year Cash Flow (PVCF) = ₽30b
After calculating the present value of future cash flows in the initial 10-year period, we need to calculate the Terminal Value, which accounts for all future cash flows beyond the first stage. The Gordon Growth formula is used to calculate Terminal Value at a future annual growth rate equal to the 5-year average of the 10-year government bond yield of 7.3%. We discount the terminal cash flows to today's value at a cost of equity of 14%.
Terminal Value (TV)= FCF2031 × (1 + g) ÷ (r – g) = ₽8.0b× (1 + 7.3%) ÷ (14%– 7.3%) = ₽120b
Present Value of Terminal Value (PVTV)= TV / (1 + r)10= ₽120b÷ ( 1 + 14%)10= ₽31b
The total value, or equity value, is then the sum of the present value of the future cash flows, which in this case is ₽61b. The last step is to then divide the equity value by the number of shares outstanding. Compared to the current share price of ₽373, the company appears around fair value at the time of writing. Valuations are imprecise instruments though, rather like a telescope - move a few degrees and end up in a different galaxy. Do keep this in mind.
Important assumptions
The calculation above is very dependent on two assumptions. The first is the discount rate and the other is the cash flows. If you don't agree with these result, have a go at the calculation yourself and play with the assumptions. The DCF also does not consider the possible cyclicality of an industry, or a company's future capital requirements, so it does not give a full picture of a company's potential performance. Given that we are looking at KuibyshevAzot as potential shareholders, the cost of equity is used as the discount rate, rather than the cost of capital (or weighted average cost of capital, WACC) which accounts for debt. In this calculation we've used 14%, which is based on a levered beta of 1.142. Beta is a measure of a stock's volatility, compared to the market as a whole. We get our beta from the industry average beta of globally comparable companies, with an imposed limit between 0.8 and 2.0, which is a reasonable range for a stable business.
Moving On:
Whilst important, the DCF calculation shouldn't be the only metric you look at when researching a company. It's not possible to obtain a foolproof valuation with a DCF model. Instead the best use for a DCF model is to test certain assumptions and theories to see if they would lead to the company being undervalued or overvalued. If a company grows at a different rate, or if its cost of equity or risk free rate changes sharply, the output can look very different. For KuibyshevAzot, we've compiled three additional factors you should look at:
- Risks: For example, we've discovered 3 warning signs for KuibyshevAzot (1 can't be ignored!) that you should be aware of before investing here.
- Other High Quality Alternatives: Do you like a good all-rounder? Explore our interactive list of high quality stocks to get an idea of what else is out there you may be missing!
- Other Top Analyst Picks: Interested to see what the analysts are thinking? Take a look at our interactive list of analysts' top stock picks to find out what they feel might have an attractive future outlook!
PS. Simply Wall St updates its DCF calculation for every Russian stock every day, so if you want to find the intrinsic value of any other stock just search here.
Valuation is complex, but we're here to simplify it.
Discover if KuibyshevAzot might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.
Access Free AnalysisThis article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
About MISX:KAZT
KuibyshevAzot
Public Joint Stock Company KuibyshevAzot, together with its subsidiaries, engages in the manufacture, distribution, and sale of various chemicals in Russia, Asia, rest of Europe, and internationally.
Outstanding track record with flawless balance sheet.